We are pleased to announce that the US FDA has granted our request for a pre-Investigational New Drug (pre-IND) Type […]
Read more : Vectus Granted FDA Pre-IND Meeting Request for VB0004 in IPFWe are pleased to announce that we are on board as a friend of ICLAF 2026. The International Colloquium on […]
Read more : ICLAF 2026Last week, Vectus Biosystems CEO Dr Tara Speranza presented at the Bioshares Biotech Summit, sharing the Company’s development strategy with […]
Read more : Vectus Presenting at Bioshares Biotech Summit
